Epidermolysis Bullosa Acquisita with Ocular Complications
Authors:
L. Drlík 1; L. Pock 2; J. Krtička 3
Authors place of work:
Dermatovenerologické oddělení, Šumperská nemocnice, a. s.
přednosta prim. MUDr. Lubomír Drlík
1; Dermatohistopatologická laboratoř, Praha
vedoucí doc. MUDr. Lumír Pock, CSc.
2; Oční ambulance, Zábřeh na Moravě
vedoucí MUDr. Jakub Krtička
3
Published in the journal:
Čes-slov Derm, 89, 2014, No. 1, p. 16-21
Category:
Case Reports
Summary
The authors present a case of a patient with epidermolysis bullosa acquisita and Crohn’s disease. The patient has been treated for 13 years with combined immunosuppressive and corticosteroid therapy with only limited morbostatic effect. Initially, classic form dominated in the clinical picture. Later, a bullous pemphigoid-like and a Brunsting-Perry pemphigoid-like lesions occurred, as well as a significant eye involvement.
Key words:
subepidermal blisters – epidermolysis bullosa acquisita – Crohn’s disease – anti-type VII collagen antibodies
Zdroje
1. BAUER, J. W., SCHAEPPI, H., METZE, D. et al. Ocular involvement in IgA-epidermolysis bullosa acqusita. Br. J. Dermatol., 1999, 141, p. 887–892.
2. BOLOGNIA, J. L., JORIZZO, J. L., RAPINI, R. P. Dermatology. 2th Ed., Mosby Elsevier, 2008, p. 441–445, ISBN 9781416029991.
3. BURNS, T., BREATHNACH, S., COX, N., GRIFFITHS, C. Rook’s Textbook of Dermatology. 8th Ed., Wiley -Blackwell Publishing Ltd., 2012, Vol. 2, p. 40.51–40.57, ISBN 978-1-4051-6169-5.
4. CAUX, F., KIRTSCHIG, G., LEMARCHAND-VENENCIE, F. et al. IgA-epidermolysis bullosa acquisita in a child resulting to blindness. Br. J. Dermatol., 1997, 137, p. 270–275.
5. CETKOVSKÁ, P., PIZINGER, K., RESL, V. Mycofenolát mofetil v léčbě vybraných kožních nemocí. Čes.-slov. Derm., 80, 2005, 1, p. 11–14.
6. CETKOVSKÁ, P., PIZINGER, K., SKÁLOVÁ, A. Klinický případ: Svědivé puchýře na končetinách a na trupu. Čes.-slov. Derm.,76, 2001, 4, s. 215–216.
7. DANTAS, P. E., NISHIWAKI-DANTAS, M. C., SEQUIM, M. H., CURSINO, J. W. Bilateral corneal involvement in epidermolysis bullosa acquisita. Cornea, 2001, 20 (6), p. 664–667.
8. DELBALDO, C., CHEN, M., FRIEDLI, A. et al. Drug-induced epidermolysis bullosa acquisita antibodies to type VII collagen. J. Am. Acad. Dermatol., 2002, 46, p. 161–164.
9. ELLIOTT, G. T., Two cases of epidermolysis bullosa. J. Cutan. Genitourinar. Dis., 1895, 13, p. 10.
10. GAMMON, W., HEISE, E., BURKE, W. et al. Increased frequency of HLA-DR2 in patients with auto-antibodies to epidermolysis bullosa acquisita antigen: evidence that expression of autoimmunity to type VII collagen is HLA class II allele assotiated. J. Invest. Dermatol., 1998, 91, p. 228–232.
11. GUPTA, R., WOODLEY, D. T., CHEN, M. Epidermolysis bullosa acquisita. Clin. Dermatol., 2012, 30 (1), p. 60–69.
12. HUNDORFEAN, G., NEURATH, M. F., SITARU, C. Autoimmunity against type VII kolagen in inflammatory bowel disease. J. Cell. Mol. Med., 2010 (10), p. 2393–2403.
13. CHEN, M., KIM, G. H., PAKASH, L. et al. Epidermolysis Bullosa Acquisita: Autoimmunity to Anchording Fibril. Autoimmunity, 2012, 45 (1), p. 91–101.
14. ISHII, N., HAMADA, T., DAINICHI, T. et al. Epidermolysis bullosa acquisita: what’s new? J. Dermatol., 2010, 37 (3), p. 220–230.
15. ISHII, N., YOSHIDA, M., HISAMATSU, Y. et al. Epidermolysis bullosa acquista sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunobloting of domain-specific recombinant proteins and postembeding immunoelectron microscopy. Br. J. Dermatol., 2004, 150, p. 843–851.
16. KIRTSCHIG, G., MURRELL, D., WOJNAROWSKA, F. et al. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch. Dermatol., 2002 (138), p. 380–384.
17. KURZHALS, G., STOLZ, W., MEURER, M. et al. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid. Arch. Dermatol., 1991, 127, p. 391–395.
18. LAFOREST, C., HUILGOL, S. C., CASSON, R. et al. Autoimmune bullous diseases: ocular manifestations and management. Drugs, 2005, 65 (13), p. 1767–1779.
19. LANG, P. G., TAPERT, M. J. Severe ocular involvement in a patient with epidermolysis bullosa acquisita. J. Am. Acad. Dermatol., 1987 (16), p. 439–443.
20. PLEWIG, G., WOLFF, H. H., LANDTHALER, M. Braun ĐFalco’s Dermatology. 3th Ed. Springer Medicin Verlag Heidelberg, 2009, p. 662–663, ISBN 278-3-540-29312-5.
21. RAAY, T. L., LEVINE, J. B., WEISS, W. et al. Epidermolysis bullosa acquisita and inflammatory bowel disease. J. Am. Acad. Dermatol., 1982 (6), p. 242–252.
22. REDDY, H., SHIPMAN, A. R., WOJNAROWSKA, F. Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature. Clin. Exp. Dermatol., 2013, 38 (3), p. 225–230.
23. SCHIMANOVICH, I., MIHAI, S., OOSTINGH, G. J. et al. Granulocyte-derivered elastase and gelatinase B are recquired for dermal-epidermal separation induced by autoantibodies from pacients with epidermolysis bullosa acquisita and bullous pemphigoid. J. Pathol., 2004, 204, p. 519–527.
24. SCHMIDT, E., HUNZELMANN, N., ZILLIKENS, D. et al. Rituximab in refractory autoimmune bullous diseases. Clin. Exp. Dermatol., 2006, 31, p. 503–508.
25. SPRAUL, C. W., BUCHWALD, H. J., LANG, G. K., LANG, G. E. Reccurent corneal ulcer in a patient with Crohn’s disease assotiated with epidermolysis bullosa acquisita. Klin. Monbl. Augenheilkd., 2003, 220 (6), p. 423–426.
26. ŠTORK, J. et al. Dermatovenerologie. Galén: Praha, 2008, p. 207–208, ISBN 978-80-7262-371-6.
27. TREBING, D., ZIEMER, A. Acquired epidermolysis bullosa acquisita with a highly varied clinical picture and successful treatment with mycophenolate mofetil. Hautarzt, 2001, 52, p. 717–721.
28. UMEMOTO, N., DEMITSU, T., TODA, S. et al. A case of nonscarring subepidermal blistering disease associated with autoantibodies reactive with both type VII collagen and laminin 5. Dermatology, 2003, 207, p. 61–64.
29. WALLET-FABER, N., FRANCK, N., BATTEUX, F. et al. Epidermolysis bullosa acquisita following bullous pemphigoid, successfuly treated with the anti-CD20 monoclonal antibody rituximab. Dermatology, 2007, 215, p. 252–255.
30. WOODLEY, D. T., CHANG, C., SADAT, P. et al. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological and immunological features of epidermolysis bullosa acquisita. J. Invest. Dermatol., 2005, 124, p. 958–964.
31. WOODLEY, D. T., CHEN, M. Epidermolysis bullosa acquisita. In Wolff, K., Goldsmith, L. A., Katz, S. I. Fitzpatrik’s Dermatology in General Medicine. 7th Ed. McGraw-Hill Medical, 2008, p. 494–500, ISBN 978-0-07-146690-5.
Štítky
Dermatology & STDs Paediatric dermatology & STDsČlánok vyšiel v časopise
Czech-Slovak Dermatology
2014 Číslo 1
Najčítanejšie v tomto čísle
- Dermatoscopy in the Diagnosis of Alopecia
- Pulse Dye Laser Treatment for Periungual Viral Warts
- Epidermolysis Bullosa Acquisita with Ocular Complications